Applied Nanotech Receives $400K Contract from California Citrus Research Board

Austin, Texas -- Applied Nanotech Holdings, Inc. (OTC QB: APNT) announced that it has received a contract from the California Citrus Research Board (CRB), worth approximately $400,000, that will fund increased instrument development and testing for HLB disease and other pathogens in citrus trees, with a focus on early detection. The contract is a Year [...]

Compact All-In-One Multiple Format Mixer

Operated via an intuitive touchscreen the Co-Mix offers effortless changing between mixing of 96- and 384-well microplates in skirted, semi-skirted and unskirted variants plus deep-well plates and PCR tubes / strips. An innovative plate holding mechanism ensures smooth manipulation of microplates eliminating sample spillage and cross-contamination problems. A vortex module enables mixing of numerous tube [...]

SeraCare Life Sciences Introduces IVD Labeled ACCURUN Controls for Women’s Health

MILFORD, Mass. -- SeraCare Life Sciences, a manufacturer of life sciences tools, bulk plasma, and quality controls for diagnostic companies and clinical laboratories, announced availability of IVD labeled ACCURUN® controls for Women's Health. These Human Papilloma Virus (HPV) and Chlamydia trachomatis/Neisseria gonorrhea (Ct/Ng) offerings are cellular-based independent controls used by clinical laboratories to challenge their [...]

ZEISS grants license for LED fluorescence excitation to Lumencor, Inc.

Jena/GERMANY, Beaverton/USA -- ZEISS has granted a license for patents relating to LED fluorescence excitation in microscopy to Lumencor, Inc., Beaverton, USA. These patents protect the use of light emitting diodes for the excitation of fluorescence radiation in light microscopes. The property rights, which are valid in the USA and Canada, were acquired by ZEISS [...]

Advanced Photonix, Inc. Reports 35% Increase in Second Quarter Revenues

ANN ARBOR, Mich. -- Advanced Photonix® (NYSE MKT: API) (the Company, we, us or our) today reported improved results for the second quarter ended September 27, 2013. Financial Highlights for the Second Quarter Ended September 27, 2013 • Net sales for the quarter were $7.5 million, an increase of $2.0 million or 35% from the [...]

Cerno Bioscience Announces Most Significant Upgrade of MassWorks™ Software Product

Norwalk, CT. – Cerno Bioscience has today announced a new version of its flagship MassWorks software product. More than any previous improvements and enhancements, the new Version 4 adds DirectRead™ data support for three high resolution MS systems: Thermo Orbitrap or FT ICR MS, Agilent TOF, and Waters TOF, while expanding unit mass resolution direct [...]

New Serological Pipettor Improves Liquid Handling Productivity

Building upon over 30 years of unmatched quality and hundreds of thousands of instruments in use worldwide - INTEGRA announces the launch of the new PIPETBOY acu 2 serological pipettor. The second generation of PIPETBOY acu is equipped with the latest technology providing a significant increase in pipetting speed and a sizeable weight reduction making [...]

New Microarray for Identifying and Subtyping Pathogenic E. coli Using Unique DNA Signatures

SANTA CLARA, Calif. -- Affymetrix, Inc. (NASDAQ: AFFX) announces the availability of a multi-genome pathogen microarray, designed by the Food and Drug Administration's Center for Food Safety and Applied Nutrition (CFSAN) and built by Affymetrix, for the detection and identification of pathogenic E. coli during foodborne outbreaks. These high density DNA-based microarray assays, for use [...]

Waters Honors School of Pharmacy at University of Maryland

MILFORD, Mass. -- Discovery and education were the main themes at a recent ceremony and symposium at the University of Maryland School of Pharmacy (UMSOP), an institution whichWaters Corporation honored for its interdisciplinary research using mass spectrometry to discover new and improved drugs to treat cancer, diabetes and infectious diseases. During an on-campus ceremony, Waters [...]

BioTime Announces Third Quarter 2013 Financial Results and Recent Corporate Accomplishments

ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the third quarter ended September 30, 2013 and highlighted recent corporate accomplishments. Third Quarter and Recent Corporate Accomplishments ? BioTime’s subsidiary, Asterias Biotherapeutics, Inc., completed its acquisition of [...]

Access IBO on Knowledge Center